Bulgaria vs Pakistan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Bulgaria
86.0%
in 2025
Pakistan
86.0%
in 2025
Bulgaria rank
92nd
Pakistan rank
92nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Bulgaria
- Pakistan
How they compare
Bulgaria currently reports 86.0% against 86.0% in Pakistan, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Pakistan ahead.
Bulgaria ranks 92nd and Pakistan ranks 92nd of 194 countries.
Bulgaria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bulgaria | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 89.1% | 53.8% | 35.3% | Bulgaria |
| 2020s | 87.0% | 84.8% | 2.2% | Bulgaria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Bulgaria or Pakistan?
- Bulgaria, at 86.0% against 86.0% in Pakistan as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Bulgaria and Pakistan?
- 0.0%, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Pakistan?
- 18 years are reported by both, from 2008 to 2025.
- How do Bulgaria and Pakistan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Bulgaria ranks 92nd and Pakistan ranks 92nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.